Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / COM STK CL A
Number of holders
117
Total Shares
105M
Shares change
-3.34M
Total reported value, excl. options
$756M
Value change
-$87.9M
Put/Call ratio
0.62
Number of buys
62
Number of sells
-86
Price
$7.17
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.